The drug "Memoplant". Instructions
The drug "Memoplant" is a means of plant origin. The active substance is the leaves of bilobate ginkgo dry extract.
Despite the fact that the mechanism of influencethe medicament is not fully understood, many experts confirm the effectiveness of the drug in disturbed mental processes. At the same time, it was found that the active ingredient significantly strengthens tissue resistance to hypoxia, slows development and accelerates the recovery of cerebral edema associated with intoxication or trauma. The active substance reduces swelling in the retina, reduces damage to the horny ocular membrane, prevents the age-related decrease in the content of alpha-2-adrenergic receptors and m-cholinergic receptors, and increases the intake of choline in the hippocampus.
Medication "Memoplant" helps to improvememory, compensation of equilibrium disorders. The drug enhances the rheological (qualitative) properties of blood, improves microcirculation, increases blood flow. It neutralizes acid radicals, has a neuroprotective effect.
The drug "Memoplant" recommends the instruction inas a symptomatic treatment of dementia (Alzheimer's and vascular type), complicated by depression, memory and concentration disorder, headache, tinnitus, dizziness. Medication is prescribed for violations in the arterial peripheral circulation, causing pain in the limbs, paresthesia, intermittent claudication, convulsions. The drug "Memoplant" recommends the instruction for dizziness, noise in the ears of involutional and vascular nature.
To eliminate the symptoms, dementia is prescribedusually one or two tablets three times a day. In disorders in the peripheral arterial blood flow, three times or two tablets are prescribed twice a day on a tablet.
The drug "Memoplant-Forte" in the first case is prescribed on a tablet three times a day, in the second - on a tablet twice a day.
The medicine is swallowed whole. Tablets should not be softened. Accepted regardless of food.
At dementia to accept a medicine "Memoplant" the instruction recommends not less than eight weeks. At the end of three months, the need and feasibility of subsequent therapy should be assessed.
For violations in the peripheral circulation of the drug take at least six weeks.
As practice shows, with noise in the ears and dizziness after the end of six to eight weeks of therapy, the subsequent improvement of the condition is unlikely.
The drug "Memoplant" instructions for use are notadmits to appointment to patients under the age of twelve (due to the lack of clinical experience in use in children), as well as with individual hypersensitivity.
As medical practice shows,manifestations when taking medication are noted in rare cases. To the undesirable effects when using the drug "Memoplant" the instruction refers to disorders in the digestive system, headache, itching, flushing, swelling and other allergic skin reactions. Long-term therapy with a medicine can contribute to the development of bleeding. However, the direct connection between their occurrence and the use of the drug has not been established.
In connection with the lack of clinical experience inuse of the drug during pregnancy and lactation, with the appointment of the drug in these periods, the doctor should evaluate the ratio of potential risk to the fetus and the likely benefits for the mother. It is not established whether extract components can be excreted into breast milk.
Cases of drug overdose in practice are not described.
Before using the drug "Memoplant" you need to consult a doctor.
